The stock of HTG Molecular Diagnostics Inc (NASDAQ:HTGM) is a huge mover today! About 4.36M shares traded hands or 740.45% up from the average. HTG Molecular Diagnostics Inc (NASDAQ:HTGM) has risen 23.26% since March 10, 2016 and is uptrending. It has outperformed by 15.74% the S&P500.
The move comes after 7 months positive chart setup for the $32.96 million company. It was reported on Oct, 13 by Barchart.com. We have $7.81 PT which if reached, will make NASDAQ:HTGM worth $42.52M more.
Analysts await HTG Molecular Diagnostics Inc (NASDAQ:HTGM) to report earnings on November, 10.
HTG Molecular Diagnostics Inc (NASDAQ:HTGM) Ratings Coverage
Out of 2 analysts covering HTG Molecular Diagnostics (NASDAQ:HTGM), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. HTG Molecular Diagnostics has been the topic of 3 analyst reports since August 24, 2015 according to StockzIntelligence Inc. Canaccord Genuity maintained HTG Molecular Diagnostics Inc (NASDAQ:HTGM) rating on Tuesday, November 24. Canaccord Genuity has “Buy” rating and $10 price target. The company was maintained on Monday, August 24 by Canaccord Genuity. The firm earned “Buy” rating on Monday, August 22 by Rodman & Renshaw.
According to Zacks Investment Research, “HTG Molecular Diagnostics, Inc. is engaged in developing and marketing a technology platform which consists of instrumentation, consumables and software analytics for sample profiling applications including tumor profiling, molecular diagnostic testing and biomarker development. Its products include HTG Edge System, HTG Edge Assays and HTG Assay Direct. HTG Molecular Diagnostics, Inc. is headquartered in Tucson, Arizona.”
More recent HTG Molecular Diagnostics Inc (NASDAQ:HTGM) news were published by: Nasdaq.com which released: “UPDATE â€“ HTG Molecular Diagnostics and Merck KGaA, Darmstadt, Germany, Enter …” on October 11, 2016. Also Quotes.Wsj.com published the news titled: “News HTG Molecular Diagnostics Inc.HTGM” on May 01, 2015. Globenewswire.com‘s news article titled: “Don Hardison Joins the Board of Directors for HTG Molecular Diagnostics” with publication date: May 03, 2016 was also an interesting one.
HTGM Company Profile
HTG Molecular Diagnostics, Inc., incorporated on December 14, 2000, is a commercial-stage firm that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company’s HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company’s HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company’s HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.